References
- CelliBRMacNeeWStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
- TamASinDDPathobiologic mechanisms of chronic obstructive pulmonary diseaseMed Clin North Am201296468169822793938
- JefferyPKRemodeling in asthma and chronic obstructive lung diseaseAm J Respir Crit Care Med2001164S28S3811734464
- RutgersSRTimensWKauffmanHFPostmaDSMarkers of active airway inflammation and remodelling in chronic obstructive pulmonary diseaseClin Exp Allergy200131219320511251621
- KuwanoKBoskenCHParePDBaiTRWiggsBRHoggJCSmall airways dimensions in asthma and in chronic obstructive pulmonary diseaseAm Rev Respir Dis19931485122012258239157
- SaettaMDi StefanoATuratoGCD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981573 Pt 18228269517597
- HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med20043502645265315215480
- TiddensHAParePDHoggJCHopWCLambertRde JongsteJCCartilaginous airway dimensions and airflow obstruction in human lungsAm J Respir Crit Care Med199515212602667599833
- LieskerJJTen HackenNHZeinstra-SmithMReticular basement membrane in asthma and COPD: similar thickness, yet different compositionInt J Chron Obstruct Pulmon Dis2009412713519436691
- KranenburgARWillems-WidyastutiAMooriWJEnhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary diseaseAm J Clin Pathol200612672573517111536
- AnnoniRLancasTTanigawaRExtracellular matrix composition in COPDEur Respir J20124061362137322496324
- IozzoRVMatrix proteoglycans: from molecular design to cellular functionAnnu Rev Biochem1998676096529759499
- RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
- CelliBRBarnesPJExacerbations of chronic obstructive pulmonary diseaseEur Respir J20072961224123817540785
- BolligerCTMathurPNBeamisJFERS/ATS statement on interventional pulmonologyEur Respir J200219235637311866017
- PiniLHamidQShannonJDifferences in proteoglycan deposition in the airways of moderate and severe asthmaticsEur Respir J2007291717717050562
- BolenderRPHydeDMDehoffRTLung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biologyAm J Physiol19932656 Pt 1L521L5488279570
- WeibelERHsiaCCOchsMHow much is there really? Why stereology is essential in lung morphometryJ Appl Physiol2007102145946716973815
- GarusiERossiSPerrisRAntithetic roles of proteoglycans in cancerCell Mol Life Sci20126955357921964924
- HasegawaMNasuharaYOnoderaYAirflow limitation and airway dimensions in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006173121309131516556695
- RuoslahtiEYamaguchiYProteoglycans as modulators of growth factor activitiesCell19916458678692001586
- BoskenCHWiggsBRParePDHoggJCSmall airway dimensions in smokers with obstruction to airflowAm Rev Respir Dis199014235635702389908
- CosioMGHaleKANiewoehnerDEMorphologic and morphometric effects of prolonged cigarette smoking on the small airwaysAm Rev Respir Dis198012222652717416603
- SaettaMTuratoGBaraldoSGoblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitationAm J Respir Crit Care Med20001613 Pt 11016102110712357